8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)
Filed: 2026-09-11 AccNo: 0001493152-26-042411 Size: 197 KB Item 8.01: Other Events
Stocks · News reference
8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)
Filed: 2026-09-09 AccNo: 0001493152-26-041901 Size: 228 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered
Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its